Literature DB >> 19112600

Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cells.

Vanity McMurtry1, Ann-Marie Simeone, René Nieves-Alicea, Ana M Tari.   

Abstract

In breast tumors, high levels of leptin have been associated with increased incidence of breast cancer metastasis. Breast cancer metastasis is directly associated with breast cancer cell invasion. However, whether leptin could augment breast cancer cell invasion is not known. Here we showed that leptin increased the invasiveness and the matrix metallo-proteinase-2 (MMP-2) activity of the MCF-7 breast cancer cell line. Leptin stimulated the phosphorylation of extracellular signals regulated kinases, signal transducers and activators of transcription 3 and Jun N-terminal kinases (JNK); however, only inhibition of JNK decreased leptin-mediated activation of MMP-2. Furthermore, inhibition of JNK suppressed leptin-mediated breast cancer cell invasion. Here we report the novel findings that leptin increased invasion of breast cancer cells by activating JNK, resulting in increased MMP-2 activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19112600     DOI: 10.1007/s10585-008-9231-x

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  52 in total

1.  Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.

Authors:  Chiachen Chen; Yuan-Ching Chang; Chien-Liang Liu; King-Jen Chang; Ing-Cherng Guo
Journal:  Breast Cancer Res Treat       Date:  2006-06-03       Impact factor: 4.872

2.  Radiommunological measurement of leptin in plasma of obese and diabetic human subjects.

Authors:  G P McGregor; J F Desaga; K Ehlenz; A Fischer; F Heese; A Hegele; C Lammer; C Peiser; R E Lang
Journal:  Endocrinology       Date:  1996-04       Impact factor: 4.736

3.  Weight change and risk of postmenopausal breast cancer (United States).

Authors:  A Trentham-Dietz; P A Newcomb; K M Egan; L Titus-Ernstoff; J A Baron; B E Storer; M Stampfer; W C Willett
Journal:  Cancer Causes Control       Date:  2000-07       Impact factor: 2.506

4.  Sequential activation and production of matrix metalloproteinase-2 during breast cancer progression.

Authors:  K S Lee; S Y Rha; S J Kim; J H Kim; J K Roh; B S Kim; H C Chung
Journal:  Clin Exp Metastasis       Date:  1996-11       Impact factor: 5.150

5.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

6.  Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line.

Authors:  Stefania Catalano; Stefania Marsico; Cinzia Giordano; Loredana Mauro; Pietro Rizza; Maria Luisa Panno; Sebastiano Andò
Journal:  J Biol Chem       Date:  2003-05-06       Impact factor: 5.157

7.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

8.  Leptin receptor-deficient MMTV-TGF-alpha/Lepr(db)Lepr(db) female mice do not develop oncogene-induced mammary tumors.

Authors:  Margot P Cleary; Subhash C Juneja; Frederick C Phillips; Xin Hu; Joseph P Grande; Nita J Maihle
Journal:  Exp Biol Med (Maywood)       Date:  2004-02

9.  Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells.

Authors:  Neeraj K Saxena; Dipali Sharma; Xiaokun Ding; Songbai Lin; Fabio Marra; Didier Merlin; Frank A Anania
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

10.  Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status.

Authors:  Amitabha Ray; Katai J Nkhata; Margot P Cleary
Journal:  Int J Oncol       Date:  2007-06       Impact factor: 5.650

View more
  14 in total

1.  Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways.

Authors:  Dan Yan; Dimiter Avtanski; Neeraj K Saxena; Dipali Sharma
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

Review 2.  Adipokine leptin in obesity-related pathology of breast cancer.

Authors:  Amitabha Ray
Journal:  J Biosci       Date:  2012-06       Impact factor: 1.826

Review 3.  Adipocytes: impact on tumor growth and potential sites for therapeutic intervention.

Authors:  Simona Hefetz-Sela; Philipp E Scherer
Journal:  Pharmacol Ther       Date:  2013-01-24       Impact factor: 12.310

4.  Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3.

Authors:  Su-Hyeong Kim; Arumugam Nagalingam; Neeraj K Saxena; Shivendra V Singh; Dipali Sharma
Journal:  Carcinogenesis       Date:  2010-12-16       Impact factor: 4.944

Review 5.  Leptin in human physiology and therapeutics.

Authors:  Tina A Dardeno; Sharon H Chou; Hyun-Seuk Moon; John P Chamberland; Christina G Fiorenza; Christos S Mantzoros
Journal:  Front Neuroendocrinol       Date:  2010-06-17       Impact factor: 8.606

Review 6.  Multifaceted leptin network: the molecular connection between obesity and breast cancer.

Authors:  Neeraj K Saxena; Dipali Sharma
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-11-10       Impact factor: 2.673

Review 7.  The potential role of leptin in tumor invasion and metastasis.

Authors:  Amitabha Ray; Margot P Cleary
Journal:  Cytokine Growth Factor Rev       Date:  2017-11-11       Impact factor: 7.638

8.  Expression of leptin, leptin receptor, adiponectin, and adiponectin receptor in ductal carcinoma in situ and invasive breast cancer.

Authors:  Young-Ju Jeong; Jin-Gu Bong; Sung-Hwan Park; Jung-Hye Choi; Hoon-Kyu Oh
Journal:  J Breast Cancer       Date:  2011-06-18       Impact factor: 3.588

9.  NFAT promotes carcinoma invasive migration through glypican-6.

Authors:  Gary K Yiu; Aura Kaunisto; Y Rebecca Chin; Alex Toker
Journal:  Biochem J       Date:  2011-11-15       Impact factor: 3.857

10.  JNK signaling maintains the mesenchymal properties of multi-drug resistant human epidermoid carcinoma KB cells through snail and twist1.

Authors:  Xia Zhan; Xiaobing Feng; Ying Kong; Yi Chen; Wenfu Tan
Journal:  BMC Cancer       Date:  2013-04-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.